Airway epithelial cells play an important role in protecting the human body against inhaled microorganisms and allergens. In addition to functioning as a physical barrier, the immune system recognizes and removes microorganisms and allergens. Interleukin (IL)-33 is a recently identifi ed member of the IL-1 family of molecules that is implicated in T helper type 2 (Th2) immune responses. Airway epithelial cells and endothelial cells in venules are thought to be the main sources of IL-33 in the lung. IL-33 has been shown to drive production of both pro-inflammatory and Th2 associated cytokines and chemokines in mast cells, Th2 lymphocytes, basophils, eosinophils, invariant natural killer (NK) T cells, and NK cells through its receptor ST2, suggesting that IL-33 has a pivotal role in allergic and non-allergic immune responses. The current model for IL-33 action is that it is released from cells undergoing necrosis and then acts as a proinfl ammatory endogenous danger signal. However, little is known regarding the mechanisms involved in production and secretion of IL-33 in airway epithelial cells.
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Many natural allergens (e.g. helminth, mites, fungi, cockroaches) that induce allergic responses or infl ammation secrete proteases or have protease activities within themselves. Airway epithelial cells recognize proteases via i.e. Protease-activated receptors (PARs) and induce Th2 type immune responses, suggesting that proteases play a pivotal role in the development of these responses. However, the mechanisms of protease-mediated Th2 responses are not fully understood.
To better understand the effect of proteases on airway epithelial cells, normal human bronchial airway epithelial (NHBE) cells were stimulated with bromelain and papain, and extracellular release and production of IL-33 in response to proteases was investigated.
To verify the expression of IL-33 in NHBE cells, we examined levels of IL-33 mRNA by real-time PCR analysis. The results showed that IL-33 mRNA was constitutively and abundantly expressed by NHBE cells without any stimulation. We examined the localization of IL-33 in resting NHBE cells by immunohistochemistry; double-staining with IL-33 Ab and DAPI showed that IL-33 was mainly localized in the nuclei. To investigate the responses to cysteine proteases by NHBE cells, we stimulated NHBE cells with cysteine proteases. After incubation with bromelain or papain for 2 h, extracellular release of IL-33 from NHBE cells was induced by proteases at low concentrations (e.g. 0.1 μg/ml for bromelain and 1μg/ml for papain, respectively). Interestingly, high concen trations of cysteine proteases inhibited IL-33 release. In contrast, cysteine proteases at high concentration (e.g. 50 μg/ml for bromelain and 100 μg/ml for papain, respectively) increased intracellular IL-33 protein, while cysteine proteases at low concentrations did not affect production. The cysteine protease inhibitor E-64 signifi cantly inhibited both extracellular release and production of IL-33.
To detect changes in the localization of IL33 protein after incubation with bromelain, cells were incubated with 0.1 μg/ml bromelain for 2 h, stained with IL33 Ab, and then examined by confocal microscopy. IL33 protein was transported from the nuclei to the cytoplasm by stimulation with 0.1 μg/ml bromelain, suggesting that IL33 release is triggered by exposure to cysteine proteases. The mechanisms of cysteine protease-mediated extracellular release and production of IL-33 by NHBE cells will be investigated further in the future.
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